WealthStone’s Celgene Corp CELG Stock Holding History

WealthStone’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-240	Closed	-$22.2K	–	725
2019 Q2	$22.2K	Buy	+240	New	+$22.8K	0.01%	210

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WealthStone's CELG Position: Q3 2019 in Review

WealthStone sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 240 shares — an estimated $22.2K sold.

WealthStone first reported a position in CELG in Q2 2019 and held it in 1 quarter. The position peaked at $22.2K in Q2 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

WealthStone reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
WealthStone sold 240 Celgene Corp shares in Q3 2019, an estimated $22.2K.
WealthStone first reported a position in Celgene Corp in Q2 2019 and held it in 1 quarter.
WealthStone's Celgene Corp position peaked at $22.2K in Q2 2019.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.